NATURAL HOLISTIC MEDICINE BLOG - The landscape for pharmaceutical commerce in Brazil is undergoing a significant transformation following a recent decision by the National Health Surveillance Agency (Anvisa). As of August 10, the agency revoked prior resolutions and preventative measures that had restricted the advertising, distribution, and commercialization of medicines on major digital marketplaces, including iFood, Rappi, Mercado Livre, Submarino, and Americanas.
This major policy shift follows the earlier authorization of Shopee, which was granted on August 6. The broader movement toward allowing these platforms to facilitate drug sales stems from the enactment of Law 15.357/2026, sanctioned in March, which updated the legislation governing the sector, specifically modifying Law 5.991/1973.
The Legislative Framework and Anvisa's Stance
The legislative update, Law 15.357/2026, aims to modernize how pharmaceuticals reach the consumer by allowing pharmacies to operate within supermarkets, provided they maintain a space strictly delimited and exclusive for pharmaceutical activities. Furthermore, the law permits licensed pharmacies to contract with digital channels and e-commerce platforms for logistical and delivery services, emphasizing that the final product dispensation must still occur under the supervision of a licensed pharmacy.
However, industry stakeholders are urged to proceed with caution regarding the interpretation of these changes. According to a report released on August 13 by XP Varejo, Anvisa clarified that the revocation of previous restrictions does not equate to an automatic, blanket authorization for these platforms to begin selling medications immediately. The agency has stated that sales through these digital channels remain contingent upon the issuance of specific, future regulations, for which no timeline has yet been established.
Marketplace Positioning and Competitive Strategy
Despite the lack of finalized regulations, major e-commerce players are already positioning themselves to capture this potential market share. Shopee has demonstrated high levels of activity, launching a rapid delivery service—often under four hours—that leverages a network of over 4,000 sellers, spanning from fresh supermarket items and frozen goods to pet products and apparel.
Competitors like Mercado Livre (MELI) are reportedly developing similar strategies, utilizing motorcycle courier networks to serve supermarkets. Analysts suggest that these existing logistical infrastructures could be seamlessly adapted to support the last-mile delivery requirements of pharmacies, with MELI potentially benefiting from the scale of a 3P (third-party) operation compared to its current 1P (first-party) pilot model in Brazil.
Pharmaceutical Industry Concerns
The prospect of increased digital marketplace involvement has met with significant resistance from the traditional pharmaceutical retail sector. At a recent industry event featuring major pharmaceutical manufacturers and pharmacy chains, the consensus among analysts and executives was a coordinated push to highlight the sanitary risks associated with a more flexible regulatory framework.
The pharmacy sector's concerns are backed by data; a report by XP Varejo noted that the pharmacy association conducted an audit of 4,900 advertisements on marketplaces, discovering that 64% exhibited regulatory irregularities, particularly in the weight-loss category. This audit underscores the primary fear that, without stringent oversight, the digital marketplace model could compromise patient safety and regulatory compliance.
The Future of Prescription and Non-Prescription Sales
The distinction between Over-the-Counter (OTC) drugs and prescription medicines remains a critical line of defense for the industry. While delivery apps like iFood and Rappi have long handled non-controlled, non-prescription items, the pharmacy sector remains aligned in its opposition to relaxing rules for higher-risk medications.
Medications subject to special control, such as 'black-stripe' (controlled) drugs and those requiring prescription retention, remain strictly prohibited from remote transactions. With over 50% of the pharmaceutical retail market driven by prescription (RX) drugs, the industry is keen to ensure that these products remain exclusively within the purview of licensed, direct pharmacy channels rather than generalist marketplaces.
As the sector looks toward the Abrafarma Future Trends 2026 and beyond, the debate over marketplace integration is expected to intensify. While delivery apps represent an incremental revenue source for platforms like Mercado Livre, analysts caution that the economics of such a model may ultimately prove less efficient than the specialized, high-margin fulfillment models currently employed by established pharmacy chains.
Frequently Asked Questions (FAQ)
Does Anvisa's revocation mean I can buy any medicine on marketplaces now?
No. The revocation of previous restrictions does not mean immediate authorization for the sale of all medicines. Anvisa has stated that specific regulations must still be issued for each platform, and there is no confirmed timeline for when these rules will be finalized.
What does the new Law 15.357/2026 change for pharmacies?
The law allows for the installation of pharmacies within supermarkets, provided they have a separate, dedicated area for pharmaceutical activities. It also allows licensed pharmacies to use digital platforms and third-party logistics for delivery, though the actual dispensing of the medication must still be conducted by a licensed pharmacy.
Why are pharmacy associations concerned about marketplace sales?
The primary concern is public health and safety. Pharmacy associations have cited audits showing that a high percentage (64%) of existing pharmaceutical advertisements on marketplaces contain irregularities. They argue that a more flexible framework could increase these risks.
Can I order controlled or prescription drugs via these apps?
No. Medications subject to special control, including those that are 'black-stripe' or require prescription retention, cannot be transacted remotely. This area remains strictly regulated to ensure safety and compliance.
Comments